Distinguishing Aortic Valve Thrombus From Libman–Sacks Endocarditis in Antiphospholipid Syndrome: Imaging and Management

References

• Rachwan RJ , DaherGE, FaresJ, RachoinR. Complete resolution of a large bicuspid aortic valve thrombus with anticoagulation in primary antiphospholipid syndrome. Front Cardiovasc. Med., 4, 59 (2017).
   PubMed Web of Science ®Google Scholar
• Arnautovic JZ , YamasakiH, RosmanHS. Multiple embolic strokes as a result of Libman–Sacks endocarditis associated with lupus and secondary antiphospholipid antibody syndrome: a case report. Eur. Heart J. Case Rep., 2(3), yty094 (2018).
   PubMedGoogle Scholar
• Malvar B , AlmeidaFM, RebochoL, MonizJC, AzevedoF. Cerebral embolism from Libman–Sacks endocarditis. BMJ Case Rep., 2011 (2011). https://doi.org/10.1136/bcr.04.2011.4071
   PubMedGoogle Scholar
• Turiel M , Sarzi-PuttiniP, PerettiRet al. Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome. Am. J. Cardiol., 96(4), 574–579 (2005).
   PubMed Web of Science ®Google Scholar
• Cervera R . Recent advances in antiphospholipid antibody-related valvulopathies. J. Autoimmun., 15(2), 123–125 (2000).
   PubMed Web of Science ®Google Scholar
• Roldan CA , QuallsCR, SopkoKS, SibbittWLJr. Transthoracic versus transesophageal echocardiography for detection of Libman–Sacks endocarditis: a randomized controlled study. J. Rheumatol., 35(2), 224–229 (2008).
   PubMed Web of Science ®Google Scholar
• Cervera R . Coronary and valvular syndromes and antiphospholipid antibodies. Thromb. Res., 114(5–6), 501–507 (2004).
   PubMedGoogle Scholar
• Lev S , ShoenfeldY. Cardiac valvulopathy in the antiphospholipid syndrome. Clin. Rev. Allergy Immunol., 23(3), 341–348 (2002).
   PubMed Web of Science ®Google Scholar
• Brito FA , TófaniMLMC, TófaniFA, KakehasiAM, LannaCCD, CarvalhoMAP. Libman–Sacks endocarditis and oral anticoagulation. Arq. Bras. Cardiol., 82(4), 378–383 (2004).
   PubMedGoogle Scholar
• Denas G , JoseSP, BraccoA, ZoppellaroG, PengoV. Antiphospholipid syndrome and the heart: a case series and literature review. Autoimmun. Rev., 14(3), 214–222 (2015).
   PubMed Web of Science ®Google Scholar
• Soltész P , SzekaneczZ, KissE, ShoenfeldY. Cardiac manifestations in antiphospholipid syndrome. Autoimmun. Rev., 6(6), 379–386 (2007).
   PubMed Web of Science ®Google Scholar
• Nesher G , IlanyJ, RosenmannD, AbrahamAS. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin. Arthritis Rheum., 27(1), 27–35 (1997).
   PubMed Web of Science ®Google Scholar
• Hojnik M , GeorgeJ, ZiporenL, ShoenfeldY. Heart valve involvement (Libman–Sacks endocarditis) in the antiphospholipid syndrome. Circulation, 93(8), 1579–1587 (1996).
   PubMed Web of Science ®Google Scholar
• Mavrogeni SI , SfikakisPP, KitasGD, KolovouG, TektonidouMG. Cardiac involvement in antiphospholipid syndrome: the diagnostic role of noninvasive cardiac imaging. Semin. Arthritis Rheum., 45(5), 611–616 (2016).
   PubMed Web of Science ®Google Scholar
• García-Torres R , AmigoMC, dela Rosa A, MorónA, ReyesPA. Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings. Lupus, 5(1), 56–61 (1996).
   PubMed Web of Science ®Google Scholar
• Shindo S , KubotaK, MatsumotoM. Thromboembolism from the noncoronary cusp of a patient with a normal aortic valve and protein C deficiency. J. Thorac. Cardiovasc. Surg., 131(5), 1171–1172 (2006).
   PubMed Web of Science ®Google Scholar
• Espínola-Zavaleta N , Vargas-BarrónJ, Colmenares-GalvisTet al. Echocardiographic evaluation of patients with primary antiphospholipid syndrome. Am. Heart J., 137(5), 973–978 (1999).
   PubMed Web of Science ®Google Scholar
• Roldan CA , TolstrupK, MaciasLet al. Libman–Sacks endocarditis: detection, characterization, and clinical correlates by three-dimensional transesophageal echocardiography. J. Am. Soc. Echocardiogr., 28(7), 770–779 (2015).
   PubMed Web of Science ®Google Scholar
• Shroff H , BenensteinR, FreedbergR, MehlS, SaricM. Mitral valve Libman–Sacks endocarditis visualized by real time three-dimensional transesophageal echocardiography. Echocardiography, 29(4), E100–E101 (2012).
   PubMed Web of Science ®Google Scholar
• Makkar RR , FontanaG, JilaihawiHet al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N. Engl. J. Med., 373(21), 2015–2024 (2015).
   PubMed Web of Science ®Google Scholar
• Tanis W , HabetsJ, vanden Brink RBA, SymerskyP, BuddeRPJ, ChamuleauSAJ. Differentiation of thrombus from pannus as the cause of acquired mechanical prosthetic heart valve obstruction by non-invasive imaging: a review of the literature. Eur. Heart J. Cardiovasc. Imaging, 15(2), 119–129 (2014).
   PubMed Web of Science ®Google Scholar
• Doherty JU , KortS, MehranRet al. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 appropriate use criteria for multimodality imaging in valvular heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J. Nucl. Cardiol., 24(6), 2043–2063 (2017).
   PubMedGoogle Scholar
• Weinsaft JW , KimRJ, RossMet al. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. JACC Cardiovasc. Imaging, 2(8), 969–979 (2009).
   PubMed Web of Science ®Google Scholar
• Goyal P , WeinsaftJW. Cardiovascular magnetic resonance imaging for assessment of cardiac thrombus. Methodist Debakey Cardiovasc. J., 9(3), 132–136 (2013).
   PubMedGoogle Scholar
• Barkhausen J , HunoldP, EggebrechtHet al. Detection and characterization of intracardiac thrombi on MR imaging. AJR Am. J. Roentgenol., 179(6), 1539–1544 (2002).
   PubMed Web of Science ®Google Scholar
• Gouya H , CabanesL, MouthonL, PavieA, LegmannP, VignauxO. Severe mitral stenosis as the first manifestation of systemic lupus erythematosus in a 20-year-old woman: the value of magnetic resonance imaging in the diagnosis of Libman–Sacks endocarditis. Int. J. Cardiovasc. Imaging, 30(5), 959–960 (2014).
   PubMed Web of Science ®Google Scholar
• Elagha A , MohsenA. Cardiac MRI clinches diagnosis of Libman–Sacks endocarditis. Lancet, 393(10182), e39 (2019).
   PubMed Web of Science ®Google Scholar
• Kitano T , SengokuK, ItotagawaE, TodoK. Dynamic morphological changes in Libman–Sacks endocarditis under different anticoagulation regimens. BMJ Case Rep., 12(4), (2019).
   PubMedGoogle Scholar
• Agirbasli MA , HansenDE, ByrdBF3rd. Resolution of vegetations with anticoagulation after myocardial infarction in primary antiphospholipid syndrome. J. Am. Soc. Echocardiogr., 10(8), 877–880 (1997).
   PubMed Web of Science ®Google Scholar
• Pengo V , RuffattiA, LegnaniCet al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J. Thromb. Haemost., 8(2), 237–242 (2010).
   PubMed Web of Science ®Google Scholar
• Tan BE , ThongBYH, ShivanandaS, HanWW, ChngHH. Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort. Lupus, 18(8), 752–758 (2009).
   PubMed Web of Science ®Google Scholar
• Neville C , RauchJ, KassisJet al. Antiphospholipid antibodies predict imminent vascular events independently from other risk factors in a prospective cohort. Thromb. Haemost., 101(1), 100–107 (2009).
   PubMed Web of Science ®Google Scholar
• Cervera R , SerranoR, Pons-EstelGJet al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann. Rheum. Dis., 74(6), 1011–1018 (2015).
   PubMed Web of Science ®Google Scholar
• Levine SR , BreyRL, TilleyBCet al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA, 291(5), 576–584 (2004).
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G , CuadradoMJ, Ruiz-ArruzaIet al. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus, 20(2), 206–218 (2011).
   PubMed Web of Science ®Google Scholar
• Finazzi G , MarchioliR, BrancaccioVet al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J. Thromb. Haemost., 3(5), 848–853 (2005).
   PubMed Web of Science ®Google Scholar
• Crowther MA , GinsbergJS, JulianJet al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N. Engl. J. Med., 349(12), 1133–1138 (2003).
   PubMed Web of Science ®Google Scholar
• Pengo V , Ruiz-IrastorzaG, DenasG, AndreoliL, KhamashtaM, TincaniA. High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: “PROS” and “CONS”. Autoimmun. Rev., 11(8), 577–580 (2012).
   PubMed Web of Science ®Google Scholar
• Andrade D , CerveraR, CohenHet al. 15th International Congress on Antiphospholipid Antibodies Task Force on antiphospholipid syndrome treatment trends report. In: Antiphospholipid Syndrome: Current Research Highlights and Clinical Insights.ErkanD, LockshinMD ( Eds). Springer International Publishing, Cham, Switzerland, 317–338 (2017).
   Google Scholar
• Okuma H , KitagawaY, YasudaT, TokuokaK, TakagiS. Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome. Int. J. Med. Sci., 7(1), 15–18 (2009).
   PubMed Web of Science ®Google Scholar
• Ohnishi N , FujiedaY, HisadaRet al. Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome. Rheumatology, 58(6), 969–974 (2019).
   PubMed Web of Science ®Google Scholar
• Cohen H , HuntBJ, EfthymiouMet al. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, Phase II/III, non-inferiority trial. Lancet Haematol., 3(9), e426–e436 (2016).
   PubMed Web of Science ®Google Scholar
• Dufrost V , RisseJ, ReshetnyakTet al. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis. Autoimmun. Rev., 17(10), 1011–1021 (2018).
   PubMed Web of Science ®Google Scholar
• Pengo V , DenasG, ZoppellaroGet al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood, 132(13), 1365–1371 (2018).
   PubMed Web of Science ®Google Scholar
• Foroughi M , HekmatM, GhorbaniM, GhaderiH, MajidiM, BeheshtiM. Mitral valve surgery in patients with systemic lupus erythematosus. ScientificWorldJournal, 2014, 216291 (2014).
   PubMedGoogle Scholar
• Gorki H , MalinovskiV, StanbridgeRDL. The antiphospholipid syndrome and heart valve surgery. Eur. J. Cardiothorac. Surg., 33(2), 168–181 (2008).
   PubMed Web of Science ®Google Scholar
• Ciocca RG , ChoiJ, GrahamAM. Antiphospholipid antibodies lead to increased risk in cardiovascular surgery. Am. J. Surg., 170(2), 198–200 (1995).
   PubMed Web of Science ®Google Scholar
• Colli A , MestresCA, EspinosaGet al. Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases. Eur. J. Cardiothorac. Surg., 37(1), 154–158 (2010).
   PubMed Web of Science ®Google Scholar
• Bouma W , KlinkenbergTJ, vander Horst ICCet al. Mitral valve surgery for mitral regurgitation caused by Libman–Sacks endocarditis: a report of four cases and a systematic review of the literature. J. Cardiothorac. Surg., 5, 13 (2010).
   PubMed Web of Science ®Google Scholar
• Morin AM , BoyerAS, NatafP, GandjbakhchI. Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature. Thorac. Cardiovasc. Surg., 44(6), 313–316 (1996).
   PubMed Web of Science ®Google Scholar